Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Core Insights - Adicet Bio, Inc. is a clinical stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer [2] - The company is advancing a pipeline of "off-the-shelf" gamma delta T cells engineered with chimeric antigen receptors (CARs) to ensure durable activity in patients [2] Event Participation - Chen Schor, President and CEO of Adicet Bio, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on February 8, 2024, at 3:00 p.m. ET [1] - The event will be accessible via a live audio webcast on Adicet Bio's website, with an archived replay available for 30 days post-presentation [1]